Event
Pharmacology and Acute Effects of Different Psychedelics
Current clinical trials with psychedelics mostly use psilocybin. However, there are other classic psychedelics such as LSD, DMT and mescaline that may be useful. The presentation will give an overview on the substances currently used in clinical trials and then focus on the acute effect characteristics of different psychedelics.
Speakers
Professor of Clinical Pharmacology and Internal Medicine
Prof. Dr. Matthias Liechti
University Hospital, Basel
View Speaker Profile
Related Events
Mechanisms of Action of Psychedelics – Implication for Psychedelic-Assisted Therapy
Keynotes & Talks
Research on the clinical application of psychedelics is gaining momentum. However major knowledge gaps remain regarding the mechanisms of action underlying beneficial therapeutic effects of these substances. Understanding the clinical mechanisms o…
Psychedelics – A “Solution” for the Mental Health Crisis?
Keynotes & Talks
Psychiatric disorders represent a major challenge for global health. According to the World Health Organization (WHO), approximately 300 million people worldwide suffer from depression, and even more are affected by anxiety disorders. If substance…
Old Medicines, New Misunderstandings
Keynotes & Talks
Over two short years, Australia has gone from having no clinical psychedelic trials to multiple trials and training programs, substantial scientific, medical, and public interest, and a large government funding round specifically for psychedelic r…
The German EPIsoDE-Trial – Study Design, Rationale and Current Status
Keynotes & Talks
This presentation will go over the preliminary evidence for the efficacy and safety of psilocybin, a serotonergic psychedelic acting as a partial 5-HT2A agonist, in the treatment of treatment-resistant depression (TRD) and other psychiatric condit…
Psychological and Neuroscience Based Approaches to the Treatment of Depression with Psychedelics
Keynotes & Talks
Recent integrative psychological and neuroscientific approaches to depression highlight that the self is a core dimension of depression. The self in depression is characterized by an increased self-focus associated with negative emotion and increa…
